- Home
- About Us
- Our Products
- Investors
- News
- New Product Pipeline
- Contact Us
News and Media
- Pharmaxis CEO
- Pharmaxis announces sustained benefit in cystic fibrosis following long term bronchitol treatment
- Pharmaxis provides FDA resubmission for Aridol US marketing application
- Recording of Investor Conference Call - 15 April 2010
- Pharmaxis Announces Milestone in Phase 3 Trial for Cystic Fibrosis
- Conference Call Details - Quarterly Report to Shareholders and Investor Conference Call
- Pharmaxis Completes Phase II clinical study with ASM8 in asthma patients
- Pharmaxis completes clinical trial with the antifibrotic agent, PXS25
- Pharmaxis completes acquisition of Canadian company Topigen Pharmaceuticals Inc
- Recording of Investor Conference Call - 28 January 2010
- Conference Call Details - Quarterly Report to Shareholders and Investor Conference Call
- Pharmaxis to acquire Canadian company TOPIGEN Pharmaceuticals Inc.
- Pharmaxis receives response letter from the FDA on Aridol application
- Pharmaxis lodges TGA application to market Bronchitol™ for CF in Australia
- Pharmaxis Announces Sustained Benefit with Bronchitol in Phase 3 Cystic Fibrosis Trial
Investor Information
ASX ANNOUNCEMENTS
- 16.11.2011 - Pharmaxis announces pro-rata entitlement offer to raise up to approximately A$80 million
- 09.11.2011 - Pharmaxis Announces PBAC Decision on Bronchitol
- 24.10.2011 - Pharmaxis Announces Major Milestone: Positive Bronchitol Opinion for Europe
- 24.10.2011 - Recording of Investor Conference Call - 24 October 2011
Category:
ASX Announcements Archive: 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003
MEDIA RELEASES
- 16.11.2011 - Pharmaxis announces pro-rata entitlement offer to raise up to approximately A$80 million
- 09.11.2011 - Pharmaxis Announces PBAC Decision on Bronchitol
- 24.10.2011 - Pharmaxis Announces Major Milestone: Positive Bronchitol Opinion for Europe
- 24.10.2011 - Recording of Investor Conference Call - 24 October 2011
Category:
Media Releases Archive: 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003
QUARTERLY REPORTS
- 16.11.2011 - Pharmaxis announces pro-rata entitlement offer to raise up to approximately A$80 million
- 09.11.2011 - Pharmaxis Announces PBAC Decision on Bronchitol
- 24.10.2011 - Pharmaxis Announces Major Milestone: Positive Bronchitol Opinion for Europe
- 24.10.2011 - Recording of Investor Conference Call - 24 October 2011
Category:
Quarterly Reports Archive: 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004